The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Abstract
BACKGROUND: Acute myocardial infarction can be triggered by acute respiratory infections. Previous studies have suggested an association between influenza and acute myocardial infarction, but those studies used nonspecific measures of influenza infection or study designs that were susceptible to bias. We evaluated the association between laboratory-confirmed influenza infection and acute myocardial infarction. METHODS: We used the self-controlled case-series design to evaluate the association between laboratory-confirmed influenza infection and hospitalization for acute myocardial infarction. We used various high-specificity laboratory methods to confirm influenza infection in respiratory specimens, and we ascertained hospitalization for acute myocardial infarction from administrative data. We defined the "risk interval" as the first 7 days after respiratory specimen collection and the "control interval" as 1 year before and 1 year after the risk interval. RESULTS: We identified 364 hospitalizations for acute myocardial infarction that occurred within 1 year before and 1 year after a positive test result for influenza. Of these, 20 (20.0 admissions per week) occurred during the risk interval and 344 (3.3 admissions per week) occurred during the control interval. The incidence ratio of an admission for acute myocardial infarction during the risk interval as compared with the control interval was 6.05 (95% confidence interval [CI], 3.86 to 9.50). No increased incidence was observed after day 7. Incidence ratios for acute myocardial infarction within 7 days after detection of influenza B, influenza A, respiratory syncytial virus, and other viruses were 10.11 (95% CI, 4.37 to 23.38), 5.17 (95% CI, 3.02 to 8.84), 3.51 (95% CI, 1.11 to 11.12), and 2.77 (95% CI, 1.23 to 6.24), respectively. CONCLUSIONS: We found a significant association between respiratory infections, especially influenza, and acute myocardial infarction. (Funded by the Canadian Institutes of Health Research and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., & Vallance, P. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041747 · Cited by 1,375
Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
Carrat, F., Vergu, E., Ferguson, N. M., Lemaitre, M., Cauchemez, S., Leach, S., & Valleron, A.-J. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm375 · Cited by 1,133
Incubation periods of acute respiratory viral infections: a systematic review
Lessler, J., Reich, N. G., Brookmeyer, R., Perl, T. M., Nelson, K. E., & Cummings, D. A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70069-6 · Cited by 883
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
Austin, P. C., Daly, P. A., & Tu, J. V. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123839 · Cited by 525
Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
Williams, W. W., Lu, P.-J., O’Halloran, A., Kim, D. K., Grohskopf, L. A., Pilishvili, T., Skoff, T. H., Nelson, N. P., Harpaz, R., Markowitz, L. E., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6501a1 · Cited by 500
Role of acute infection in triggering acute coronary syndromes
Corrales-Medina, V. F., Madjid, M., & Musher, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70331-7 · Cited by 462
Influenza and the Winter Increase in Mortality in the United States, 1959-1999
Reichert, T. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh227 · Cited by 451
Corrales-Medina, V. F., Musher, D. M., Wells, G. A., Chirinos, J. A., Chen, L., & Fine, M. J. (2012) · Circulation · doi:10.1161/circulationaha.111.040766 · Cited by 414
Madjid, M., Miller, C. C., Zarubaev, V. V., Marinich, I. G., Kiselev, O. I., Lobzin, Y. V., Filippov, A. E., & Casscells, S. W. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm035 · Cited by 311
Influenza vaccines for preventing cardiovascular disease
Clar, C., Oseni, Z., Flowers, N., Keshtkar-Jahromi, M., & Rees, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005050.pub3 · Cited by 214
EXCESS MORTALITY FROM EPIDEMIC INFLUENZA, 1957–1966
HOUSWORTH, J., & LANGMUIR, A. D. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112007 · Cited by 211
Warren-Gash, C., Hayward, A. C., Hemingway, H., Denaxas, S., Thomas, S. L., Timmis, A. D., Whitaker, H., & Smeeth, L. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis597 · Cited by 205
Excess Mortality from Causes Other than Influenza and Pneumonia during Influenza Epidemics
Collins, S. D. (1932) · Public Health Reports (1896-1970) · doi:10.2307/4580606 · Cited by 198
A STUDY OF EXCESS MORTALITY DURING INFLUENZA EPIDEMICS IN THE UNITED STATES, 1968–19761
ALLING, D. W., BLACKWELDER, W. C., & STUART-HARRIS, C. H. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113063 · Cited by 169
Excess Deaths Attributable to Influenza in England and Wales: Age at Death and Certified Cause
TILLETT, H. E., SMITH, J. W. G., & GOOCH, C. D. (1983) · International Journal of Epidemiology · doi:10.1093/ije/12.3.344 · Cited by 146
Warren‐Gash, C., Bhaskaran, K., Hayward, A. C., Leung, G. M., Lo, S., Wong, C.-M., Ellis, J., Pebody, R. G., Smeeth, L. L., & Cowling, B. J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir171 · Cited by 132
Darvishian, M., Bijlsma, M. J., Hak, E., & van den Heuvel, E. R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70960-0 · Cited by 123
Ip, D., Lau, L. L., Chan, K., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ909 · Cited by 106
Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study
MacIntyre, C. R., Heywood, A. E., Kovoor, P., Ridda, I., Seale, H., Tan, T. C., Gao, Z., Katelaris, A. L., Siu, D. H. W., Lo, V., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304320 · Cited by 97
Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction
Guan, X., Yang, W. P., Sun, X.-J., Wang, L., Ma, B.-J., Li, H., & Zhou, J. (2012) · Inflammation Research · doi:10.1007/s00011-012-0449-3 · Cited by 96
Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects
FOSTER, E. D., Cavanaugh, J. E., Haynes, W. G., Yang, M. H., Gerke, A. K., Tang, F., & Polgreen, P. M. (2013) · Epidemiology and Infection · doi:10.1017/s0950268812002890 · Cited by 47
The exposure-crossover design is a new method for studying sustained changes in recurrent events
Redelmeier, D. A. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.05.003 · Cited by 37
Viral and mycoplasmal antibodies in patients with myocardial infarction.
Pönkä, A., Jalanko, H., Pönkä, T., et al. (1981) · PubMed · Cited by 27
Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977
Mantón, K. G., & Stallard, E. (1982) · Demography · doi:10.2307/2061017 · Cited by 26
FluSTAR, A Novel Influenza Surveillance System: Outcomes from the 2005–2006 Flu Season
Aull, L., Blumentals, W. A., Iacuzio, D. A., & Cheng, S. J. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e31813c6b34 · Cited by 4
Cited by
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
Potential Effects of Coronaviruses on the Cardiovascular System: A Review
Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1286 · Cited by 1,793
Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,570
Metadata
- Authors
- Kwong, J. C., Schwartz, K. L., Campitelli, M. A., Chung, H., Crowcroft, N. S., Karnauchow, T., Katz, K., Ko, D. T., McGeer, A. J., McNally, D., Richardson, D. C., Rosella, L. C., Simor, A., Smieja, M., Zahariadis, G., & Gubbay, J. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-01-25
- Volume
- 378
- Issue
- 4
- Pages
- 345-353
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2785715721
- Cited by
- 1,199
- References
- 29
- FWCI
- 108.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.